The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
from NYT > Well https://ift.tt/mfD69yB
via IFTTT
Thursday, September 29, 2022
FDA Approves ALS Treatment Despite Questions About Effectiveness
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment